140 are missing
after glacier breaks
in India’s Himalayas
RISHIKESH, India — Indian rescue crews struggled to reach trapped victims Sunday after part of a glacier in the Himalayas broke off and released a torrent of water and debris that slammed into two hydroelectric plants. At least nine people were killed and 140 were missing in a disaster experts said appeared to point to global warming.
Video from India’s northern state of Uttarakhand showed the muddy, concrete-gray floodwaters tumbling through a valley and surging into a dam, breaking it into pieces with little resistance before roaring on downstream. The flood turned the countryside into what looked like an ash-colored moonscape.
More than 2,000 members of the military, paramilitary groups and police took part in the search-and-rescue operation, including soldiers expert in mountaineering, working into the night under bright halogen lights, authorities said.
The flood was caused when a portion of Nanda Devi glacier snapped off in the morning, releasing water trapped behind it, authorities said. It rushed down the mountain and into other bodies of water, forcing the evacuation of many villages along the banks of the Alaknanda and Dhauliganga rivers.
A hydroelectric plant on the Alaknanda was destroyed, and a plant under construction on the Dhauliganga was damaged, said Vivek Pandey, a spokesman for the paramilitary Indo Tibetan Border Police. Flowing out of the Himalayan mountains, the two rivers meet before merging with the Ganges River.
Pandey said at least 42 workers were trapped in two tunnels at the Dhauliganga project. Twelve were rescued from one of the tunnels, while at least 30 others remained stranded inside the other, he said.
“The rescuers used ropes and shovels to reach the mouth of the tunnel. They dug through the debris and entered the tunnel. They are yet to come in touch with the stranded people,” said Chief Minister Trivendra Singh Rawat, Uttarakhand’s top elected official.
UK vaccine gambles
paid off, while EU
caution slowed it down
SAINT-HERBLAIN, France — French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate.
The buyer? The United Kingdom — not the European Union, as might be expected for a company on the banks of the Loire.
“What a true waste,” bristled Christelle Morancais, president of the Pays de la Loire regional council, as she tried to wrap her head around the missed opportunity. The British, she told The Associated Press, “rolled out the red carpet for this company, helping with financing and the set-up. … And we were powerless.”
The U.K. has now ordered another 40 million doses and has options for more from Valneva, which has a plant in Scotland. The EU is still in talks with the company.
That pattern of Britain investing aggressively and early while the EU takes a slower, more cautious approach has been the hallmark of the vaccine race in Europe — and offers a window into problems that have dogged the vaccination rollout by the world’s biggest trading bloc.
South Africa suspends its AstraZeneca vaccine drive
JOHANNESBURG — South Africa has suspended plans to inoculate its front-line health care workers with the Oxford-AstraZeneca vaccine after a small clinical trial suggested that it isn’t effective in preventing mild to moderate illness from the variant dominant in the country.
South Africa received its first 1 million doses of the AstraZeneca vaccine last week and was expected to begin giving jabs to health care workers in mid-February. The disappointing early results indicate that an inoculation drive using the AstraZeneca vaccine may not be useful.
Preliminary data from a small study suggested that the AstraZeneca vaccine offers only “minimal protection against mild-moderate disease” caused by the variant in South Africa. The variant appears more infectious and is driving a deadly resurgence of the disease in the country, currently accounting for more than 90% of the COVID-19 cases, health minister Zweli Mkhize said Sunday night.
“The AstraZeneca vaccine appeared effective against the original strain, but not against the variant,” Mkhize said. “We have decided to put a temporary hold on the rollout of the vaccine … more work needs to be done.”
The study, which hasn’t yet been peer-reviewed, involved 2,000 people, most of whom were young and healthy. The volunteers’ average age was 31.
In pandemic, more people choose to die at home
MISSION, Kan. — Mortuary owner Brian Simmons has been making more trips to homes to pick up bodies to be cremated and embalmed since the pandemic hit.
With COVID-19 devastating communities in Missouri, his two-person crews regularly arrive at homes in the Springfield area and remove bodies of people who decided to die at home rather than spend their final days in a nursing home or hospital where family visitations were prohibited during the pandemic.
He understands all too well why people are choosing to die at home: His own 49-year-old daughter succumbed to the coronavirus just before Christmas at a Springfield hospital, where the family only got phone updates as her condition deteriorated.
“The separation part is really rough, rough rough,” said Simmons. “My daughter went to the hospital and we saw her once through the glass when they put her on the ventilator, and then we never saw her again until after she died.”
Across the country, terminally ill patients — both with COVID-19 and other diseases — are making similar decisions and dying at home rather than face the terrifying scenario of saying farewell to loved ones behind glass or during video calls.
Next stop Mars: Three spacecraft arriving
in quick succession
CAPE CANAVERAL, Fla. — After hurtling hundreds of millions of miles through space since last summer, three robotic explorers are ready to hit the brakes at Mars.
The stakes — and anxiety — are sky high.
The United Arab Emirates’ orbiter reaches Mars on Tuesday, followed less than 24 hours later by China’s orbiter-rover combo. NASA’s rover, the cosmic caboose, will arrive on the scene a week later, on Feb. 18, to collect rocks for return to Earth — a key step in determining whether life ever existed at Mars.
Both the UAE and China are newcomers at Mars, where more than half of Earth’s emissaries have failed. China’s first Mars mission, a joint effort with Russia in 2011, never made it past Earth’s orbit.
“We are quite excited as engineers and scientists, at the same time quite stressed and happy, worried, scared,” said Omran Sharaf, project manager for the UAE.
Analysis: Trump’s
Senate trial matters regardless of outcome
WASHINGTON — This matters.
The outcome may seem preordained in the unprecedented second impeachment trial of Donald Trump.
Democrats prosecuting the former president for inciting a deadly insurrection at the U.S. Capitol will struggle to persuade at least 17 Republicans to convict Trump and bar him from office. Forty-five of the 50 Republican senators backed a bid last month to dismiss the trial, essentially telegraphing how the final vote will play out.
But the trial set to begin Tuesday is ultimately a test of whether a president, holding an office that many of the nation’s founders feared could become too powerful in the wrong hands, is above the law. Senators will be forced to sit still, listen to evidence and wrestle with elemental questions about American democracy. There will be visual, visceral evidence, and the American people will also be sitting in their own form of judgment as they watch.
The verdict and the process itself will be scrutinized for generations.
